Bmi1 is required for tumorigenesis in a mouse model of intestinal cancer

Oncogene

Volumn 33, Issue 28, 2014, Pages 3742-3747

  Maynard, M A ^a   Ferretti, R ^a   Hilgendorf, K I ^a   Perret, C ^b   Whyte, P ^c   Lees, J A ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b INSTITUT COCHIN   (France)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Apc; apoptosis; Arf; Bmi1; colorectal cancer; intestine

Indexed keywords

BETA CATENIN; BMI1 PROTEIN; CASPASE 3; MYC PROTEIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENOTYPE; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; INTESTINE EPITHELIUM; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

MUS;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE MODELS, ANIMAL; FEMALE; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; MALE; MICE; POLYCOMB REPRESSIVE COMPLEX 1; PROTO-ONCOGENE PROTEINS;

EID: 84904251251     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.333     Document Type: Article

References (25)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
2. Fearon ER. Molecular genetics of colorectal cancer. Ann Rev Pathol 2011; 6: 479-507.
3. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death-fromcancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 2005; 115: 1503-1521. (Pubitemid 40814659)
4. Tateishi K, Ohta M, Kanai F, Guleng B, Tanaka Y, Asaoka Y et al. Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract. Clin Cancer Res 2006; 12: 6960-6966. (Pubitemid 44974489)
5. Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, Li SX et al. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 2010; 136: 997-1006.
6. Yu T, Chen X, Zhang W, Colon D, Shi J, Napier D et al. Regulation of the potential marker for intestinal cells, Bmi1, by beta-catenin and the zinc finger protein KLF4: implications for colon cancer. J Biol Chem 2012; 287: 3760-3768.
7. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 1994; 8: 757-769.
8. Fasano CA, Dimos JT, Ivanova NB, Lowry N, Lemischka IR, Temple S. shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell 2007; 1: 87-99. (Pubitemid 46865801)
9. Gieni RS, Hendzel MJ. Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer. Biochem Cell Biol 2009; 87: 711-746.
10. Subkhankulova T, Zhang X, Leung C, Marino S. Bmi1 directly represses p21Waf1/ Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors. Mol Cell Neurosci 2010; 45: 151-162.
11. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 2009; 29: 8884-8896.
12. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-611.
13. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nature Genet 2008; 40: 915-920. (Pubitemid 351913652)
14. van der Flier LG, van Gijn ME, Hatzis P, Kujala P, Haegebarth A, Stange DE et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009; 136: 903-912.
15. Tian H, Biehs B, Warming S, Leong KG, Rangell L, Klein OD et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011; 478: 255-259.
16. Colnot S, Niwa-Kawakita M, Hamard G, Godard C, Le Plenier S, Houbron C et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest 2004; 84: 1619-1630. (Pubitemid 39600569)
17. el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 2004; 39: 186-193. (Pubitemid 39079517)
18. Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO et al. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res 2007; 67: 9721-9730. (Pubitemid 47621219)
19. Grinstein E, Wernet P. Cellular signaling in normal and cancerous stem cells. Cell Signal 2007; 19: 2428-2433. (Pubitemid 47531926)
20. Sherr CJ, Bertwistle D, DENB W, Kuo ML, Sugimoto M, Tago K et al. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol 2005; 70: 129-137. (Pubitemid 44124864)
21. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91: 649-659. (Pubitemid 27513656)
22. Gibson SL, Dai CY, Lee HW, DePinho RA, Gee MS, Lee WM et al. Inhibition of colon tumor progression and angiogenesis by the Ink4a/Arf locus. Cancer Res 2003; 63: 742-746. (Pubitemid 36231968)
23. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71. (Pubitemid 29036285)
24. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367.
25. Tallquist MD, Soriano P. Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs extra-embryonic gene function. Genesis 2000; 26: 113-115. (Pubitemid 30158091)